nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.02.2012

The Role of Prolonged Viral Gastrointestinal Infections in the Development of Immunodeficiency-Related Enteropathy

verfasst von: Annick A. J. M. van de Ven, David P. Hoytema van Konijnenburg, Annemarie M. J. Wensing, Joris M. van Montfrans

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Patients with primary immunodeficiencies are prone to develop enteropathy of unknown pathogenesis. We hypothesize that ineffective clearance of gastrointestinal pathogens, particularly viruses, in combination with defective immune regulation may cause inflammatory enteropathy in certain immunodeficient hosts. We reviewed publications related to prolonged enteric viral infection, immunodeficiency, and the subsequent development of inflammatory enteropathy. Prolonged infection with especially enteroviral infections was reported more often in immunocompromised hosts than in healthy individuals. Protracted enteric viral shedding was not always associated with the presence or duration of gastrointestinal symptoms. The development of immunodeficiency-associated enteropathy after prolonged viral infections was described in sporadic cases. Clinical consequences of viral gut infections in immunocompromised hosts comprise isolation issues and supportive care. Prospective studies in cohorts of immunodeficient patients are required to study the impact of prolonged enteric viral replication with respect to the pathogenesis of non-infectious enteropathy.

MacDonald TT (2002) The biochemical basis of immune enteropathy. J Pediatr Gastroenterol Nutr 34(Suppl 1):S27–S30PubMedCrossRef

Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411(6837):603–606PubMedCrossRef

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411(6837):599–603PubMedCrossRef

Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A et al (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39(5):596–604PubMedCrossRef

Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K et al (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39(2):207–211PubMedCrossRef

Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40(8):955–962PubMedCrossRef

Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL (1994) Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1(7):553–562PubMedCrossRef

Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463PubMedCrossRef

Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A et al (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132(5):1657–1664PubMedCrossRef

10.

Perlmann P, Broberger O (1960) Auto-antibodies against antigen derived from colon in the microsomes of regional colonic lymph glands in human ulcerative colitis. Nature 188:749–751PubMedCrossRef

11.

Takahashi F, Das KM (1985) Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest 76(1):311–318PubMedCrossRef

12.

Montgomery SM, Morris DL, Pounder RE, Wakefield AJ (1999) Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 116(4):796–803PubMedCrossRef

13.

Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE et al (2010) Virus-plus-susceptibility gene interaction determines Crohn’s disease gene Atg16L1 phenotypes in intestine. Cell 141(7):1135–1145PubMedCrossRef

14.

Abramowsky CR, Sorensen RU (1988) Regional enteritis-like enteropathy in a patient with agammaglobulinemia: histologic and immunocytologic studies. Hum Pathol 19(4):483–486PubMedCrossRef

15.

Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92(1):34–48PubMedCrossRef

16.

Washington K, Stenzel TT, Buckley RH, Gottfried MR (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20(10):1240–1252PubMedCrossRef

17.

Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K (1982) Incidence and prevalence of ulcerative colitis and Crohn’s disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 83(3):563–568PubMed

18.

Brahme F, Lindstrom C, Wenckert A (1975) Crohn’s disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmo, Sweden. Gastroenterology 69(2):342–351PubMed

19.

Devlin HB, Datta D, Dellipiani AW (1980) The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 4(2):183–193PubMedCrossRef

20.

Stonnington CM, Phillips SF, Melton LJ III, Zinsmeister AR (1987) Chronic ulcerative colitis: incidence and prevalence in a community. Gut 28(4):402–409PubMedCrossRef

21.

Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B et al (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112(2):277–286PubMedCrossRef

22.

Lederman HM, Winkelstein JA (1985) X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64(3):145–156

23.

Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R et al (2008) Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46(10):1547–1554PubMedCrossRef

24.

Amar CF, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin J (2007) Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case–control Infectious Intestinal Disease Study (1993–1996). Eur J Clin Microbiol Infect Dis 26(5):311–323PubMedCrossRef

25.

MacLennan C, Dunn G, Huissoon AP, Kumararatne DS, Martin J, O’Leary P et al (2004) Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363(9420):1509–1513PubMedCrossRef

26.

van de Ven AAJM, Douma JW, Rademaker C, van Loon AM, Wensing AM, Boelens JJ et al (2011) Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antivir Ther 16(4):611–614PubMedCrossRef

27.

Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361(18):1776–1785PubMedCrossRef

28.

Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14(8):1224–1231PubMedCrossRef

29.

Okhuysen PC, Jiang X, Ye L, Johnson PC, Estes MK (1995) Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis 171(3):566–569PubMedCrossRef

30.

Siebenga JJ, Beersma MF, Vennema H, van Biezen P, Hartwig NJ, Koopmans M (2008) High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution. J Infect Dis 198(7):994–1001PubMedCrossRef

31.

Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH et al (2008) Norwalk virus shedding after experimental human infection. Emerg Infect Dis 14(10):1553–1557PubMedCrossRef

32.

Aoki Y, Suto A, Mizuta K, Ahiko T, Osaka K, Matsuzaki Y (2010) Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients. J Hosp Infect 75(1):42–46PubMedCrossRef

33.

Murata T, Katsushima N, Mizuta K, Muraki Y, Hongo S, Matsuzaki Y (2007) Prolonged norovirus shedding in infants < or = 6 months of age with gastroenteritis. Pediatr Infect Dis J 26(1):46–49PubMedCrossRef

34.

Tu ET, Bull RA, Kim MJ, McIver CJ, Heron L, Rawlinson WD et al (2008) Norovirus excretion in an aged-care setting. J Clin Microbiol 46(6):2119–2121PubMedCrossRef

35.

Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M et al (2010) Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: a novel cause. J Clin Virol 49(3):219–222PubMedCrossRef

36.

Gallimore CI, Lewis D, Taylor C, Cant A, Gennery A, Gray JJ (2004) Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). J Clin Virol 30(2):196–204PubMedCrossRef

37.

Lee BE, Pang XL, Robinson JL, Bigam D, Monroe SS, Preiksaitis JK (2008) Chronic norovirus and adenovirus infection in a solid organ transplant recipient. Pediatr Infect Dis J 27(4):360–362PubMedCrossRef

38.

Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M et al (2011) Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 117(22):5850–5856PubMedCrossRef

39.

Henke-Gendo C, Harste G, Juergens-Saathoff B, Mattner F, Deppe H, Heim A (2009) New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol 47(9):2855–2862PubMedCrossRef

40.

Simon A, Schildgen O, Maria Eis-Hubinger A, Hasan C, Bode U, Buderus S et al (2006) Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 41(6):693–699PubMedCrossRef

41.

Ludwig A, Adams O, Laws HJ, Schroten H, Tenenbaum T (2008) Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J Med Virol 80(8):1461–1467PubMedCrossRef

42.

Khan RR, Lawson AD, Minnich LL, Martin K, Nasir A, Emmett MK et al (2009) Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48(3):328–333PubMedCrossRef

43.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C et al (2010) Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362(4):289–298PubMedCrossRef

44.

Widdowson MA, Bresee JS, Gentsch JR, Glass RI (2005) Rotavirus disease and its prevention. Curr Opin Gastroenterol 21(1):26–31PubMed

45.

Cunliffe NA, Gondwe JS, Kirkwood CD, Graham SM, Nhlane NM, Thindwa BD et al (2001) Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 358(9281):550–555PubMedCrossRef

46.

Rayani A, Bode U, Habas E, Fleischhack G, Engelhart S, Exner M et al (2007) Rotavirus infections in paediatric oncology patients: a matched-pairs analysis. Scand J Gastroenterol 42(1):81–87PubMedCrossRef

47.

Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R (1998) Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 351(9119):1844–1848PubMedCrossRef

48.

Mata L, Simhon A, Urrutia JJ, Kronmal RA, Fernandez R, Garcia B (1983) Epidemiology of rotaviruses in a cohort of 45 Guatamalan Mayan Indian children observed from birth to the age of three years. J Infect Dis 148(3):452–461PubMedCrossRef

49.

Rodriguez-Baez N, O’Brien R, Qiu SQ, Bass DM (2002) Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr 35(1):64–68PubMedCrossRef

50.

Saulsbury FT, Winkelstein JA, Yolken RH (1980) Chronic rotavirus infection in immunodeficiency. J Pediatr 97(1):61–65PubMedCrossRef

51.

Ramani S, Sankaran P, Arumugam R, Sarkar R, Banerjee I, Mohanty I et al (2010) Comparison of viral load and duration of virus shedding in symptomatic and asymptomatic neonatal rotavirus infections. J Med Virol 82(10):1803–1807PubMedCrossRef

52.

Wilde J, Yolken R, Willoughby R, Eiden J (1991) Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337(8737):323–326PubMedCrossRef

53.

Gilger MA, Matson DO, Conner ME, Rosenblatt HM, Finegold MJ, Estes MK (1992) Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 120(6):912–917PubMedCrossRef

54.

Mori I, Matsumoto K, Sugimoto K, Kimura M, Daimon N, Yokochi T et al (2002) Prolonged shedding of rotavirus in a geriatric inpatient. J Med Virol 67(4):613–615PubMedCrossRef

55.

Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM et al (2010) Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 362(4):314–319PubMedCrossRef

56.

Uygungil B, Bleesing JJ, Risma KA, McNeal MM, Rothenberg ME (2010) Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: a reason to screen. J Allergy Clin Immunol 125(1):270–271PubMedCrossRef

57.

Werther RL, Crawford NW, Boniface K, Kirkwood CD, Smart JM (2009) Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J Allergy Clin Immunol 124(3):600PubMedCrossRef

58.

Yolken R, Kinney J, Wilde J, Willoughby R, Eiden J (1990) Immunoglobulins and other modalities for the prevention and treatment of enteric viral infections. J Clin Immunol 10(6 Suppl):80S–86SPubMedCrossRef

59.

Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L et al (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101(10):2333–2340PubMedCrossRef

60.

Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S et al (2006) In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 3(9):e358PubMedCrossRef

61.

Pavone P, Nicolini E, Taibi R, Ruggieri M (2007) Rotavirus and celiac disease. Am J Gastroenterol 102(8):1831PubMedCrossRef

62.

DeGroote G, Desmyter J, Vantrappen G, Phillips CA (1977) Rotavirus antibodies in Crohn’s disease and ulcerative colitis. Lancet 1(8024):1263–1264CrossRef

63.

Lenz D, Hambsch J, Schneider P, Hausler HJ, Sauer U, Hess J et al (2003) Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Crit Care 7(2):185–190PubMedCrossRef

64.

Cheng LL, Ng PC, Chan PK, Wong HL, Cheng FW, Tang JW (2006) Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 118(3):e929–e933PubMedCrossRef

65.

Chung PW, Huang YC, Chang LY, Lin TY, Ning HC (2001) Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 34(3):167–170PubMed

66.

Koci MD (2005) Immunity and resistance to astrovirus infection. Viral Immunol 18(1):11–16PubMedCrossRef

67.

Hennessey KA, Lago H, Diomande F, koua-Koffi C, Caceres VM, Pallansch MA et al (2005) Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d’Ivoire. J Infect Dis 192(12):2124–2128PubMedCrossRef

68.

Pavlov DN, Van Zyl WB, Van HJ, Kruger M, Blignaut L, Grabow WO et al (2006) Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. J Appl Microbiol 101(6):1367–1379PubMedCrossRef

69.

Pavlov DN, Van Zyl WB, Kruger M, Blignaut L, Grabow WO, Ehlers MM (2006) Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Diagn Microbiol Infect Dis 54(1):23–30PubMedCrossRef

70.

Alexander JP Jr, Gary HE Jr, Pallansch MA (1997) Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 175(Suppl 1):S176–S182PubMedCrossRef

71.

Martin J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G et al (2004) Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 78(24):13839–13847PubMedCrossRef

72.

MacCallum FO (1971) Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia. Spec Rep Ser Med Res Counc (G B) 310:72–85

73.

Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A (1999) Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265(2):178–184PubMedCrossRef

74.

Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L et al (1998) Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36(10):2893–2899PubMed

75.

Martin J, Dunn G, Hull R, Patel V, Minor PD (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74(7):3001–3010PubMedCrossRef

76.

Yang CF, Chen HY, Jorba J, Sun HC, Yang SJ, Lee HC et al (2005) Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 79(20):12623–12634PubMedCrossRef

77.

Halsey NA, Pinto J, Espinosa-Rosales F, Faure-Fontenla MA, da Silva E, Khan AJ et al (2004) Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ 82(1):3–8PubMed

78.

Fiore L, Plebani A, Buttinelli G, Fiore S, Donati V, Marturano J et al (2004) Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. Clin Immunol 111(1):98–102PubMedCrossRef

79.

Triki H, Barbouche MR, Bahri O, Bejaoui M, Dellagi K (2003) Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol 41(3):1203–1211PubMedCrossRef

80.

Asturias EJ, Grazioso CF, Luna-Fineman S, Torres O, Halsey NA (2006) Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer. Biologicals 34(2):109–112PubMedCrossRef

81.

Gouandjika-Vasilache I, koua-Koffi C, Begaud E, Dosseh A (2005) No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health 10(8):743–747PubMedCrossRef

82.

Khetsuriani N, Helfand R, Pallansch M, Kew O, Fowlkes A, Oberste MS et al (2009) Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis 9:136PubMedCrossRef

83.

Halliday E, Winkelstein J, Webster AD (2003) Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect 46(1):1–8PubMedCrossRef

84.

Bailly JL, Chambon M, Henquell C, Icart J, Peigue-Lafeuille H (2000) Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain. J Clin Microbiol 38(2):552–557PubMed

85.

Johnson JP, Yolken RH, Goodman D, Winkelstein JA, Nagel JE (1982) Prolonged excretion of group A coxsackievirus in an infant with agammaglobulinemia. J Infect Dis 146(5):712PubMedCrossRef

86.

Liste MB, Natera I, Suarez JA, Pujol FH, Liprandi F, Ludert JE (2000) Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children. J Clin Microbiol 38(8):2873–2877PubMed

87.

Archimbaud C, Bailly JL, Chambon M, Tournilhac O, Travade P, Peigue-Lafeuille H (2003) Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000. J Clin Microbiol 41(10):4605–4610PubMedCrossRef

88.

Dunn JJ, Romero JR, Wasserman R, Rotbart HA (2000) Stable enterovirus 5′ nontranslated region over a 7-year period in a patient with agammaglobulinemia and chronic infection. J Infect Dis 182(1):298–301PubMedCrossRef

89.

Cellier C, Foray S, Hermine O (2000) Regional enteritis associated with enterovirus in a patient with X-linked agammaglobulinemia. N Engl J Med 342(21):1611–1612PubMedCrossRef

90.

Gallimore CI, Taylor C, Gennery AR, Cant AJ, Galloway A, Lewis D et al (2005) Use of a heminested reverse transcriptase PCR assay for detection of astrovirus in environmental swabs from an outbreak of gastroenteritis in a pediatric primary immunodeficiency unit. J Clin Microbiol 43(8):3890–3894PubMedCrossRef

91.

Mitchell DK, Monroe SS, Jiang X, Matson DO, Glass RI, Pickering LK (1995) Virologic features of an astrovirus diarrhea outbreak in a day care center revealed by reverse transcriptase-polymerase chain reaction. J Infect Dis 172(6):1437–1444PubMedCrossRef

92.

Maldonado Y, Cantwell M, Old M, Hill D, Sanchez ML, Logan L et al (1998) Population-based prevalence of symptomatic and asymptomatic astrovirus infection in rural Mayan infants. J Infect Dis 178(2):334–339PubMed

93.

Trevino M, Prieto E, Penalver D, Aguilera A, Garcia-Zabarte A, Garcia-Riestra C et al (2001) Diarrhea caused by adenovirus and astrovirus in hospitalized immunodeficient patients. Enferm Infecc Microbiol Clin 19(1):7–10PubMed

94.

Gallimore CI, Taylor C, Gennery AR, Cant AJ, Galloway A, Iturriza-Gomara M et al (2006) Environmental monitoring for gastroenteric viruses in a pediatric primary immunodeficiency unit. J Clin Microbiol 44(2):395–399PubMedCrossRef

95.

Noel J, Cubitt D (1994) Identification of astrovirus serotypes from children treated at the Hospitals for Sick Children, London 1981–93. Epidemiol Infect 113(1):153–159PubMedCrossRef

96.

Cunliffe NA, Dove W, Gondwe JS, Thindwa BD, Greensill J, Holmes JL et al (2002) Detection and characterisation of human astroviruses in children with acute gastroenteritis in Blantyre, Malawi. J Med Virol 67(4):563–566PubMedCrossRef

97.

Ferreira RG, Borges AM, Fiaccadori FS, Souza MB, Santos RA, Cardoso DD (2010) Gastroenteric virus detection in fecal samples from women in Goiania, State of Goias, Brazil. Rev Soc Bras Med Trop 43(3):240–243PubMedCrossRef

98.

Smits SL, van Leeuwen M, van der Eijk AA, Fraaij PL, Escher JC, Simon JH et al (2010) Human astrovirus infection in a patient with new-onset celiac disease. J Clin Microbiol 48(9):3416–3418PubMedCrossRef

99.

Uhnoo I, Svensson L, Wadell G (1990) Enteric adenoviruses. Baillieres Clin Gastroenterol 4(3):627–642PubMedCrossRef

100.

Hierholzer JC (1992) Adenoviruses in the immunocompromised host. Clin Microbiol Rev 5(3):262–274PubMed

101.

Van R, Wun CC, O’Ryan ML, Matson DO, Jackson L, Pickering LK (1992) Outbreaks of human enteric adenovirus types 40 and 41 in Houston day care centers. J Pediatr 120(4 Pt 1):516–521PubMed

102.

Adrian T, Schafer G, Cooney MK, Fox JP, Wigand R (1988) Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect 101(3):503–509PubMedCrossRef

103.

Munoz FM, Piedra PA, Demmler GJ (1998) Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 27(5):1194–1200PubMedCrossRef

104.

Curlin ME, Huang ML, Lu X, Celum CL, Sanchez J, Selke S et al (2010) Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men. PLoS One 5(6):e11321PubMedCrossRef

105.

Kagnoff MF, Austin RK, Hubert JJ, Bernardin JE, Kasarda DD (1984) Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 160(5):1544–1557PubMedCrossRef

106.

Kagnoff MF, Paterson YJ, Kumar PJ, Kasarda DD, Carbone FR, Unsworth DJ et al (1987) Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 28(8):995–1001PubMedCrossRef

107.

Carter MJ, Willcocks MM, Mitchison HC, Record CO, Madeley CR (1989) Is a persistent adenovirus infection involved in coeliac disease? Gut 30(11):1563–1567PubMedCrossRef

108.

Mahon J, Blair GE, Wood GM, Scott BB, Losowsky MS, Howdle PD (1991) Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut 32(10):1114–1116PubMedCrossRef

109.

Rabeneck L (1994) AIDS enteropathy: what’s in a name? J Clin Gastroenterol 19(2):154–157PubMedCrossRef

110.

Cello JP, Day LW (2009) Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 136(6):1952–1965PubMedCrossRef

111.

La Brooy JT (1993) Enteropathy in HIV infection. J Acquir Immune Defic Syndr 6(Suppl 1):S16–S19PubMed

112.

Mitra AK, Hernandez CD, Hernandez CA, Siddiq Z (2001) Management of diarrhoea in HIV-infected patients. Int J STD AIDS 12(10):630–639PubMedCrossRef

113.

Thomas PD, Pollok RC, Gazzard BG (1999) Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1(1):19–24PubMedCrossRef

114.

Rockx B, De WM, Vennema H, Vinje J, De BE, Van DY et al (2002) Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 35(3):246–253PubMedCrossRef

115.

Iwakiri A, Ganmyo H, Yamamoto S, Otao K, Mikasa M, Kizoe S et al (2009) Quantitative analysis of fecal sapovirus shedding: identification of nucleotide substitutions in the capsid protein during prolonged excretion. Arch Virol 154(4):689–693PubMedCrossRef

116.

Gallimore CI, Appleton H, Lewis D, Green J, Brown DW (1995) Detection and characterisation of bisegmented double-stranded RNA viruses (picobirnaviruses) in human faecal specimens. J Med Virol 45(2):135–140PubMedCrossRef

117.

Grohmann GS, Glass RI, Pereira HG, Monroe SS, Hightower AW, Weber R et al (1993) Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. N Engl J Med 329(1):14–20PubMedCrossRef

118.

Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK (1995) Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 108(1):225–230PubMedCrossRef

119.

Pinsky BA, Mix S, Rowe J, Ikemoto S, Baron EJ (2010) Long-term shedding of influenza A virus in stool of immunocompromised child. Emerg Infect Dis 16(7):1165–1167PubMedCrossRef

120.

Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L et al (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9(5):548–553PubMedCrossRef

121.

Dorner T, Radbruch A (2007) Antibodies and B cell memory in viral immunity. Immunity 27(3):384–392PubMedCrossRef

122.

Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18):1141–1149PubMedCrossRef

123.

Vieira P, Rajewsky K (1990) Persistence of memory B cells in mice deprived of T cell help. Int Immunol 2(6):487–494PubMedCrossRef

124.

Agarwal S, Mayer L (2009) Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 124(4):658–664PubMedCrossRef

125.

Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L (2011) Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis 17(1):251–259PubMedCrossRef

126.

Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M et al (2007) Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 52(11):2977–2983PubMedCrossRef

127.

Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J et al (2010) The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 105(10):2262–2275PubMedCrossRef

128.

Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C et al (2007) Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27(3):308–316PubMedCrossRef

129.

Teahon K, Webster AD, Price AB, Weston J, Bjarnason I (1994) Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 35(9):1244–1249PubMedCrossRef

130.

Daniels JA, Lederman HM, Maitra A, Montgomery EA (2007) Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 31(12):1800–1812PubMedCrossRef

131.

Labadie K, Pelletier I, Saulnier A, Martin J, Colbere-Garapin F (2004) Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells. Virology 318(1):66–78PubMedCrossRef

Titel: The Role of Prolonged Viral Gastrointestinal Infections in the Development of Immunodeficiency-Related Enteropathy
verfasst von: Annick A. J. M. van de Ven
David P. Hoytema van Konijnenburg
Annemarie M. J. Wensing
Joris M. van Montfrans
Publikationsdatum: 01.02.2012
Verlag: Humana Press Inc
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 1/2012
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-011-8292-9

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The Role of Prolonged Viral Gastrointestinal Infections in the Development of Immunodeficiency-Related Enteropathy

Abstract

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Hygiene Hypothesis and Autoimmune Diseases

Leaky Gut and Autoimmune Diseases

The Therapeutic Potential of Epigenetics in Autoimmune Diseases

Molecular Mimicry as a Mechanism of Autoimmune Disease

Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders

Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO